National patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure.
about
Optimizing drug therapy in patients with cardiovascular disease: the impact of pharmacist-managed pharmacotherapy clinics in a primary care settingHeart failure: Part IIOutpatient management of heart failure in the United States, 2006-2008.Underutilization of ACE inhibitors in heart failure.Heart failure: Part I. First hospitalization and post-hospital care.Evaluation of the use of evidence-based angiotensin-converting enzyme inhibitor criteria for the treatment of congestive heart failure: opportunities for pharmacists to improve patient outcomes.Angiotensin II receptor blockers in heart failure.Heart failure disease management: impact on hospital care, length of stay, and reimbursement.A personalized medicine target: heart failure in womenSpironolactone use in patients with heart failure.Effects of an enhanced secondary prevention program for patients with heart disease: a prospective randomized trial.Race and socioeconomic status influence outcomes of unrelated donor hematopoietic cell transplantation.Sex, quality of care, and outcomes of elderly patients hospitalized with heart failure: findings from the National Heart Failure Project.The gap between knowledge and practice in the treatment and prevention of cardiovascular disease.Elevations in serum creatinine concentration: concerning or reassuring?Angiotensin-converting enzyme inhibitor use in elderly patients hospitalized with heart failure and left ventricular systolic dysfunction.
P2860
Q28193213-5D007334-6A51-4A96-BF99-52F0999F516FQ33708950-932903EB-7C26-4D7D-AA80-6251EBEC2C60Q33766193-EE56AA8B-E649-4873-A027-397DBC3E72DDQ33771359-BA26A4F0-E896-45F2-BDE7-AEAB95432F95Q34190471-84472573-6216-4C13-80C2-6CABFE589288Q34419187-77440B63-A23A-4B0C-8B95-DF89066FC809Q35066800-EE2D3F54-7D68-46CF-BAC8-E1027CBCD032Q35097107-AB5FF385-861C-4BFF-AFFF-2179BA90948CQ35201772-E21BE6A3-83EE-4020-97DD-A6A38E700F1DQ35739720-D4788D05-65DF-45CA-ADC9-E4D94394841DQ37119082-3DED06B7-F726-4D98-B78B-5545B6CB1756Q37417841-5D20DD53-7DEB-4AF9-856E-595652EBEC30Q37465167-BD42AAD9-1B96-4BCC-9336-C44A46F99CFAQ40661597-DD4BAA65-69F8-4E46-83A7-11DF339854ADQ44910338-8A0BC9E3-C594-43EE-8E81-F3E5A51D0507Q45140974-76B1FE51-96E6-442D-92DF-36EA0A17A061
P2860
National patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
National patterns of angiotens ...... e in congestive heart failure.
@en
National patterns of angiotens ...... e in congestive heart failure.
@nl
type
label
National patterns of angiotens ...... e in congestive heart failure.
@en
National patterns of angiotens ...... e in congestive heart failure.
@nl
prefLabel
National patterns of angiotens ...... e in congestive heart failure.
@en
National patterns of angiotens ...... e in congestive heart failure.
@nl
P2093
P1476
National patterns of angiotens ...... e in congestive heart failure.
@en
P2093
Blumenthal D
Stafford RS
P304
P356
10.1001/ARCHINTE.157.21.2460
P407
P577
1997-11-01T00:00:00Z